Clinical Trial

5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region

Study acronym: HAT
Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
Hepatic echinococcosis (HE) is a serious endemic parasitic disease in high-altitude regions like Xizang. Radical hepatectomy is the primary curative treatment, but expert resources are often concentrated in large medical centers. This prospective, single-arm study aims to evaluate the feasibility and safety of performing remote robotic hepatectomy using the Chinese Toumai™ robotic system over a 5G network. Ten patients in West China Hospital Tibet Hospital, Sichuan University (Lhasa, 3650m altitude) will undergo surgery performed by expert surgeons at West China Hospital (Chengdu). The primary focus is the surgical success rate and perioperative safety.
Trial Details
NCT Number NCT07551063
Lead Sponsor West China Hospital
Collaborators: West China Hospital Tibet Hospital, Sichuan University
Conditions Hepatic Echinococcosis
Enrollment 10 participants
Start Date 2026-05-01
Primary Completion 2026-10-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-24